CarBon Study
Developing new treatment options for large bone defects and osteoarthritis.
6 academic partners, 3 companies and 3 charitable foundations, working together to train 14 young scientists.
Combining expertise
The consortium combines expertise from cell biology, matrix biology and mechanical engineering. Furthermore, involvement of experts in innovative computational modelling will enable us to bring our research to a new level, maximising the use of all the experimental data generated, significantly improving the identification/ prediction of robust therapeutic targets.
Training Early Stage Researchers
CarBon is training 14 high potential scientists to combine knowledge of cartilage & bone developmental biology, pathobiology and tissue engineering with skills in cell culture, animal models, proteomics, biomaterial development, bioreactors and computational modelling.
The balance between cartilage and bone
Identification of cell secreted factors that stimulate or inhibit endochondral ossification. The extracellular matrix and development of novel biomaterial scaffolds. The mechanical environment and use of bioreactors. Towards application and development of new treatments for bone defects and osteoarthritis.
NEWS
Symposium on CarBon at EORS 2019
The European Orthopaedic Research Society (EORS) will have its annual conference in Maastricht from October 3 until October 5, 2019. On October 3 Dr. Eric Farrell (EMC), CarBon PI, will lead a symposium (symposium n. [...]
CarBon consortium members meet in Frankfurt
On July 3 and 4, 2019 CarBon PIs and ESRs met in the sunny Frankfurt for two intense days or meeting, hosted by Goethe University of Franfurt - represented by PI Prof. Frank Zaucke. All [...]
